ELOXX PHARMACEUTICALS, INC. Preferred Stock, Value, Issued
ELOXX PHARMACEUTICALS, INC. (ELOX) had Preferred Stock, Value, Issued of $0 as of 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-09-11
- 2026-06-30: Preferred Stock, Value, Issued $0.00.
- 2026-03-31: Preferred Stock, Value, Issued $0.00.
- 2025-12-31: Preferred Stock, Value, Issued $0.00.
- 2024-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-06-30 | $0.00 S-1 · filed 2026-09-11 |
| 2026-03-31 | $0.00 S-1/A · filed 2026-06-04 |
| 2025-12-31 | $0.00 S-1 · filed 2026-09-11 |
| 2024-12-31 | $0.00 S-1 · filed 2026-09-11 |
| 2023-12-31 | $0.00 S-1 · filed 2026-09-11 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-13 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2016-12-31 | $76.00K 10-K · filed 2018-03-16 |
| 2015-03-31 | $4.00 10-Q · filed 2015-05-14 |
| 2014-12-31 | $6.00 10-Q · filed 2015-02-17 |
| 2014-09-30 | $6.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $6.00 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |